Cardiomyopathy Trial, Recruiting NCT07110818 Sponsor: Montreal Heart Institute Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT07110818
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Your heart's pumping function (measured as a percentage called LVEF) is below 50%
  • Your heart's pumping function is between 50–55%, AND scans show specific changes to your heart tissue or an enlarged heart chamber, AND you carry a gene change known to cause a type of heart muscle disease not related to blocked arteries (confirm with trial site for exact gene details)

Who may not be able to join:

  • You have severely blocked heart arteries or have previously had a certain type of heart attack caused by a blocked artery
  • You have a significant heart defect present from birth that has needed treatment
  • You have a serious problem with one of your heart valves, such as significant narrowing or leaking of the aortic or mitral valve (minor valve leaking as a secondary effect is generally not a reason for exclusion)
  • Your heart condition is explained by a specific separate disease, such as amyloid heart disease, Chagas disease, Takotsubo syndrome, sarcoidosis, iron overload, or HIV-related heart disease
  • Your heart condition is thought to be caused entirely by a substance or treatment you received, such as certain medications or therapies (this is decided by your cardiologist)
  • You have a history of a specific condition called "burned out hypertrophic cardiomyopathy"
  • You have already had a heart transplant before your first heart scan (CMR) for this trial
  • You do not wish to give your consent to participate

Additional things to know:

  • This trial is open to both adults and children
  • Patients over 70 years old may be included, but their numbers are limited to a small proportion of participants per centre (confirm with trial site)
  • Having risk factors such as past chemotherapy, radiotherapy, or alcohol use does not automatically exclude you, unless your doctor believes these fully explain your heart condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 1-514-376-3330

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Montreal Heart Institute
Registry
ClinicalTrials.gov
Start date
2 April 2024
Est. completion
1 April 2030

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Time to first sustained ventricular arrhythmia; Time to first life-threatening ventricular arrhythmia; Time to (aborted) sudden cardiac death in non-ICD carriers; Atrial fibrillation and thromboembolic events:

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov